Share on StockTwits

Equities research analysts at Stifel Nicolaus raised their price objective on shares of Medidata Solutions (NASDAQ:MDSO) from $47.00 to $55.00 in a research note issued to investors on Thursday. Stifel Nicolaus’ target price points to a potential upside of 25.40% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Analysts at Topeka Capital Markets reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday. They now have a $50.00 price target on the stock, up previously from $49.00. Separately, analysts at Jefferies Group raised their price target on shares of Medidata Solutions from $50.00 to $53.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $58.37.

Medidata Solutions (NASDAQ:MDSO) traded down 2.19% during mid-day trading on Thursday, hitting $43.86. 489,755 shares of the company’s stock traded hands. Medidata Solutions has a 1-year low of $32.10 and a 1-year high of $68.21. The stock has a 50-day moving average of $41.53 and a 200-day moving average of $48.96. The company has a market cap of $2.301 billion and a P/E ratio of 367.54.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.17 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.18 by $0.01. The company had revenue of $83.20 million for the quarter, compared to the consensus estimate of $81.90 million. During the same quarter in the prior year, the company posted $0.36 earnings per share. The company’s quarterly revenue was up 22.2% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.76 EPS for the current fiscal year.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.